22 completed, 5 recruiting, 5 withdrawn, 2 unknown. 13 Not applicable, 4 Phase 2, 2 Phase 4, 1 Phase 1, 1 Phase 3.
Follow Heart Attack: new trials by email Literature Review of Heart Attack trials Research Report on Heart Attack
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Role of Stress in Cardiac Arrest (Cortizol CPR) Sample of hair - Chronic Stress, Cardiac Arrest (CA) | Not applicable | Recruiting | University Hospital Pilsen | 136 | 2026-01-08 | 2026-05-01 |
| Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence Med AAAction intervention - Diabetes, Hypertension | Not applicable | Recruiting | University of Tennessee | 388 | 2024-04-06 | 2026-01-29 |
| Immunomodulatory Effects of PCSK9 Inhibition 99mTc-tilmanocept SPECT/CT scanning - Atherosclerotic Cardiovascular Disease, Cardiovascular Diseases | Withdrawn | Massachusetts General Hospital | 2024-04-04 | 2025-09-26 | ||
| Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II AliveCor 12-lead ECG - Myocardial Infarction, Ischemia | Not applicable | Recruiting | AliveCor | 1000 | 2024-03-12 | 2026-04-09 |
| Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP) Statin, Aspirin tablet, Nexlizet - Coronary Artery Disease, Atherosclerosis | Phase 4 | Withdrawn | University of Louisville | 2024-03-01 | 2025-03-17 | |
| Coronary Computed Tomography Versus Invasive Angiography for Non-ST Elevation Acute Coronary Syndrome CCTA, Conventional ICA, Team-based interventional triage - Ischemic Heart Disease, Non STEMI | Not applicable | Recruiting | Copenhagen University Hospital, Rigshospitalet | 2300 | 2023-10-01 | 2025-02-19 |
| Mobile Advanced Multi-Parameter Reporting in Patients Wearing a Novel Device: Utilization During Cardiac Rehabilitation ZOLL Arrhythmia Management System - Heart Attack, Cardiac Event | Withdrawn | Zoll Medical Corporation | 2023-01-01 | 2023-07-24 | ||
| Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI SGLT-2 inhibitors, Placebo - Heart Attack, Enlarged Heart | Phase 2 | Recruiting | Minneapolis Heart Institute Foundation | 81 | 2022-08-03 | 2024-10-08 |
| Stress Management and Resiliency Training Following Acute Myocardial Infarction Stress Management and Resiliency Training Program - Heart Attack, Cardiovascular Diseases | Not applicable | Completed | University of California, Davis | 10 | 2022-05-11 | 2024-05-21 |
| The Role of Genetic Factors in the Development of Myocardial Infarction in the Kazakh Population DNA analysis - Heart Attack | Completed | Asfendiyarov Kazakh National Medical University | 500 | 2021-10-23 | 2023-03-14 | |
| Improving the Accuracy of Referrals of Patients With Chest Pain modified HEART score (including POC hs cTnI analysis), Standard care and triage according to the local (EMT)protocol. - Chest Pain, Acute Coronary Syndrome | Not applicable | Completed | VieCuri Medical Centre | 852 | 2021-07-04 | 2026-10-09 |
| T-MACS Decision Aid: a Randomized, Controlled Point of Care Trial Immediate discharge - Heart Attack, Chest Pain | Not applicable | Withdrawn | Manchester University NHS Foundation Trust | 2021-01-01 | 2021-01-26 | |
| Home Telemonitoring In Patients After Myocardial Infarction SmartHeart Device - Myocardial Infarction, Heart Attack | Not applicable | Completed | Mayo Clinic | 195 | 2020-10-14 | 2025-05-11 |
| A Digital Flu Intervention for People With Cardiovascular Conditions Targeted digital intervention - Cardiovascular Diseases, Atrial Fibrillation | Not applicable | Completed | Evidation Health | 49138 | 2020-09-21 | 2022-06-21 |
| Comparison of Fingerstick Versus Venous Sample for Troponin I. POC troponin analysis. - Chest Pain, Myocardial Infarction | Completed | VieCuri Medical Centre | 131 | 2019-09-03 | 2022-06-10 | |
| SINGaporean Program Performed With an eXPANsion Medical Device (SingXpand) Protheracytes - Heart Attack | Phase 1 / Phase 2 | Withdrawn | CellProthera | 2018-11-27 | 2022-06-10 | |
| The Effects of the Dietary Supplement CardioFlex Q10 on Reducing Cardiovascular Disease Risk Factors in Adults CardioFlex Q10, Placebo - Cardiovascular Diseases, Cardiovascular Abnormalities | Not applicable | Completed | University of Manitoba | 69 | 2018-11-06 | 2020-10-29 |
| Chronic Kidney Disease (CKD) Platelet Study Ticagrelor 90mg, Clopidogrel 75mg, Aspirin 81 mg - Chronic Kidney Diseases, Heart Attack | Phase 3 | Completed | University of Arkansas | 76 | 2018-11-01 | 2022-12-29 |
| The Pre-hospital Evaluation of Sensitive Troponin (PRESTO) Study Chest Pain, Acute Coronary Syndrome | Unknown | Manchester University NHS Foundation Trust | 700 | 2018-10-16 | 2024-05-01 | |
| ACS Registry - A Non-interventional Study to Estimate the Rates of Outcomes in ACS Patients in Moscow Heart Attack, Stroke | Completed | AstraZeneca | 1576 | 2018-03-25 | 2022-10-14 |
Showing 20 of 35. Sign in to see all of them.
Myocardial Infarction (35) · Cardiovascular Diseases (9) · Stroke (9) · Chest Pain (6) · Coronary Artery Disease (6) · Heart Failure (6) · Myocardial Ischemia (6) · Acute Coronary Syndrome (5) · Non-ST Elevated Myocardial Infarction (5) · Angina, Unstable (4) · Heart Diseases (4) · Angina Pectoris (3) · Arrhythmias, Cardiac (3) · Atherosclerosis (3) · Atrial Fibrillation (3)
Infarction (35) · Necrosis (35) · Pathologic Processes (35) · Pathological Conditions, Signs and Symptoms (35) · Ischemia (34) · Vascular Diseases (33) · Heart Diseases (31) · Myocardial Ischemia (29) · Cardiovascular Diseases (26) · Neurologic Manifestations (11) · Signs and Symptoms (11) · Brain Diseases (10) · Central Nervous System Diseases (10) · Cerebrovascular Disorders (10) · Nervous System Diseases (10)
Aspirin (2) · Clopidogrel (2) · Ticagrelor (2) · AC133 Antigen (1) · ALN-PCS (1) · Atorvastatin (1) · Colchicine (1) · Exercise Test (1) · Hydroxymethylglutaryl-CoA Reductase Inhibitors (1) · Magnetic Resonance Spectroscopy (1) · Prasugrel Hydrochloride (1) · Sodium-Glucose Transporter 2 Inhibitors (1) · Standard of Care (1) · Tomography, Optical Coherence (1) · eicosapentaenoic acid ethyl ester (1)
Henry Ford Health System (2) · Manchester University NHS Foundation Trust (2) · VieCuri Medical Centre (2) · AliveCor (1) · Asfendiyarov Kazakh National Medical University (1) · AstraZeneca (1) · CellProthera (1) · Copenhagen University Hospital, Rigshospitalet (1) · Evidation Health (1) · Global Healthy Living Foundation (1) · Healios K.K. (1) · Imperial College London (1) · Johns Hopkins University (1) · Kaiser Permanente (1) · Liverpool University Hospitals NHS Foundation Trust (1)
United States (17) · United Kingdom (5) · Netherlands (3) · Canada (2) · Czechia (1) · Denmark (1) · Kazakhstan (1) · Russia (1) · Singapore (1) · Switzerland (1)
Braim Rahel, Dr. (2) · Richard Body (2) · Aisulu Mussagaliyeva, PhD (1) · Aleem Khand, MbChB,MRCP (1) · Angelo A Alonzo, PhD (1) · Anshuman Sharma, MD (1) · Arbi Ben Abdallah, PhD (1) · Babar Basir, DO (1) · Cees de Vos, Dr. (1) · Daniel Helsten, MD (1) · Darya Semenova (1) · Dinesh Kalra, MD (1) · Dmitriy Privalov (1) · Elena Demyanova (1)
PMID 26418126, PMID 27028469, PMID 27665225, PMID 28954802, PMID 31025538, PMID 31662404, PMID 32518208, PMID 33606413, PMID 34011835, PMID 35119463, PMID 35224730, PMID 36206046, PMID 36682595, PMID 36909848, PMID 37306636, PMID 37704387, PMID 39806626, PMID 41360328, PMID 41528153
2019 (1), R01HL085328 (1), R44HL117572 (1)